5 completed, 1 terminated. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Terminated 1 |
Follow Dual Diagnosis: new trials by email Literature Review of Dual Diagnosis trials Research Report on Dual Diagnosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users Creatine monohydrate - Depression, Dual Diagnosis | Phase 4 | Completed | Perry Renshaw | 65 | 2014-09-01 | 2025-04-08 |
| Ondansetron for Bipolar Disorder and Alcohol Use Disorders Ondansetron, Placebo - Bipolar Disorder, Alcohol Use Disorder | Phase 4 | Completed | University of Texas Southwestern Medical Center | 70 | 2014-02-01 | 2021-08-24 |
| Clozapine for Cannabis Use in Schizophrenia Clozapine, Risperidone - Schizophrenia, Cannabis Abuse | Phase 4 | Completed | Dartmouth-Hitchcock Medical Center | 49 | 2013-05-01 | 2020-05-05 |
| Creatine as a Treatment Option for Depression in Methamphetamine Using Females Creatine monohydrate - Depression, Substance Abuse | Phase 4 | Completed | Perry Renshaw | 14 | 2013-01-01 | 2015-06-29 |
| Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual Clozapine, Treatment as usual - Schizophrenia, Dual Diagnosis | Phase 4 | Completed | Dartmouth-Hitchcock Medical Center | 31 | 2000-10-01 | 2019-03-13 |
| Alcoholism and Schizophrenia: Effects of Clozapine Clozapine versus typical (conventional) and atypical antipsychotic medications - Schizophrenia, Dual Diagnosis | Phase 4 | Terminated | Dartmouth-Hitchcock Medical Center | 64 | 1999-05-01 | 2018-03-14 |
Substance-Related Disorders (4) · Schizophrenia (3) · Alcoholism (2) · Depression (2) · Marijuana Abuse (2) · Psychotic Disorders (2) · Bipolar Disorder (1)
Chemically-Induced Disorders (6) · Mental Disorders (6) · Schizophrenia Spectrum and Other Psychotic Disorders (3) · Alcohol-Related Disorders (2) · Behavior (2) · Behavioral Symptoms (2) · Substance-Related Disorders (2) · Bipolar and Related Disorders (1) · Mood Disorders (1)
Clozapine (2) · Creatine (2) · Congresses as Topic (1) · Ondansetron (1) · Risperidone (1) · Therapeutics (1)
Dartmouth-Hitchcock Medical Center (3) · Perry Renshaw (2) · University of Texas Southwestern Medical Center (1)
United States (6)
Alan I Green, MD (2) · Perry Renshaw, MD, PhD, MBA (2) · Alan Green, MD (1) · E. Sherwood Brown, MD, PhD (1) · Tracy Hellem, RN (1)
R01DA013196 (1), R01DA032533 (1)